Sign in

OGI on Nasdaq

ORGANIGRAM GLOBAL INC.

ORGANIGRAM GLOBAL INC. is a pharmaceutical preparations company, listed on Nasdaq (OGI).1

Price unavailable

Last updated Oct 21, 2026.

Overview

159.8MRevenue, fiscal 20242
-45.4MNet income, fiscal 20242

Compare with MindWalk, MEDICURE INC or PyroGenesis Canada Inc., or pick any stock.

  • TickerOGI on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersZ41
  • Incorporated inCanada (Federal Level)3
  • Business address1400-145 King St. West, Toronto, M5H 1J83
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.

Key numbers, fiscal 2024

29.7%Gross margin2
-22.3%Operating margin2
-28.4%Net margin2
-14.9%Return on equity2
0.00×Debt to equity2
-859.0K CADFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue66¢111.4M CAD
  • Research and development7¢11.2M CAD
  • Selling, general and admin27¢45.9M CAD

Out of 159.8M CAD in revenue.2 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Capital spending100¢4.7M CAD

Out of 3.9M CAD of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.2

Financial statements

Revenue456782159.8M CAD in 2024+1186% since 2018
050.0M CAD100.0M CAD150.0M CAD200.0M CAD2018: 12.4M CAD12.4M CAD20182019: 80.4M CAD80.4M CAD2019+547%2020: 86.8M CAD86.8M CAD2020+8%2021: 79.2M CAD79.2M CAD2021−9%2022: 145.8M CAD145.8M CAD2022+84%2024: 159.8M CAD159.8M CAD2024+10%
Gross profit45678247.5M CAD in 2024−8% since 2018
-100.0M CAD-50.0M CAD050.0M CAD100.0M CAD2018: 51.6M CAD51.6M CAD20182019: 48.5M CAD48.5M CAD2019−6%2020: -56.5M CAD-56.5M CAD20202021: -28.4M CAD-28.4M CAD2021−50%2022: 31.6M CAD31.6M CAD20222024: 47.5M CAD47.5M CAD2024+51%
Operating income456782-35.7M CAD in 2024
-150.0M CAD-100.0M CAD-50.0M CAD050.0M CAD2018: 36.4M CAD36.4M CAD20182019: 5.5M CAD5.5M CAD2019−85%2020: -145.5M CAD-145.5M CAD20202021: -91.8M CAD-91.8M CAD2021−37%2022: -43.2M CAD-43.2M CAD2022−53%2024: -35.7M CAD-35.7M CAD2024−17%
Net income456782-45.4M CAD in 2024
-150.0M CAD-100.0M CAD-50.0M CAD050.0M CAD2018: 20.5M CAD20.5M CAD20182019: -9.5M CAD-9.5M CAD20192020: -136.2M CAD-136.2M CAD2020+1327%2021: -130.7M CAD-130.7M CAD2021−4%2022: -14.3M CAD-14.3M CAD2022−89%2024: -45.4M CAD-45.4M CAD2024+218%

Every line of the income statement as filed: the last 2 fiscal years, latest first.9

Period ending2025-09-302024-09-30
Gross revenue (Note 20)403.0M CAD247.2M CAD
Excise taxes-143.8M CAD-87.3M CAD
Net revenue259.2M CAD159.8M CAD
Cost of sales (Note 7 and 21)174.8M CAD111.4M CAD
Gross margin before fair value adjustments84.3M CAD48.5M CAD
Realized fair value on inventories sold and other inventory charges (Note 7)-67.1M CAD-52.1M CAD
Unrealized gain on changes in fair value of biological assets (Note 6)73.0M CAD51.2M CAD
Gross margin90.2M CAD47.5M CAD
General and administrative (Note 23)59.5M CAD45.0M CAD
Sales and marketing31.1M CAD19.9M CAD
Research and development10.9M CAD11.2M CAD
Share-based compensation (Note 14 (iv))4.0M CAD6.3M CAD
Total operating expenses105.5M CAD82.3M CAD
LOSS FROM OPERATIONS-15.3M CAD-34.8M CAD
Investment income, net of financing costs-1.1M CAD-3.3M CAD
Acquisition and transaction costs6.6M CAD915.0K CAD
Share of loss from investments in associates0 CAD5.3M CAD
Loss (gain) on disposal of property, plant and equipment and intangible assets9.0K CAD-633.0K CAD
Change in fair value of contingent consideration (Note 26)-9.7M CAD-50.0K CAD
Change in fair value of derivative liabilities, preferred shares and other financial assets (Note 11, 12 and 13)27.5M CAD7.7M CAD
Share issuance costs allocated to derivative liabilities and preferred shares (Note 14)170.0K CAD937.0K CAD
Other non-operating income-142.0K CAD-176.0K CAD
Loss before tax-38.5M CAD-45.4M CAD
Deferred, net-13.8M CAD0 CAD
NET LOSS-24.8M CAD-45.4M CAD
Change in fair value of investments at fair value through other comprehensive income (Note 11)666.0K CAD96.0K CAD
COMPREHENSIVE LOSS-24.1M CAD-45.3M CAD
Net loss per common share, basic (in CAD per share)-0.19 CAD-0.48 CAD
Net loss per common share, diluted (in CAD per share)-0.19 CAD-0.48 CAD

Compare ORGANIGRAM GLOBAL INC. with another company

Corporate structure

ORGANIGRAM GLOBAL INC. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ORGANIGRAM GLOBAL INC.

  • ORGANIGRAM GLOBAL INC. Z4

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ORGANIGRAM GLOBAL INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net96.2M CAD2 Sep 30, 202499.0M CAD2 Sep 30, 2023−2.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)10.6M CAD8 Sep 30, 202356.2M CAD8 Aug 31, 2022−81.1%

Inventory

ItemLatestA year beforeChange
Inventory, total67.4M CAD2 Sep 30, 202463.6M CAD2 Sep 30, 2023+5.9%

Former names

  • ORGANIGRAM HOLDINGS INC.Sep 1, 2016 to Apr 1, 20253
  • ORGANIGRAM HOLDINGS INCApr 13, 2015 to Jul 21, 20163

Filings

175 filings to the SEC since October 2021: 6 annual reports, 9 large holders, 160 other. The latest 20:

  1. Oct 15, 20266-K EDGAR
  2. Sep 30, 20266-K EDGAR
  3. Sep 3, 20266-K EDGAR
  4. Sep 1, 20266-K EDGAR
  5. Aug 20, 20266-K EDGAR
  6. Aug 11, 20266-K EDGAR
  7. Aug 4, 20266-K EDGAR
  8. Jul 20, 20266-K EDGAR
  9. May 12, 20266-K EDGAR
  10. May 6, 20266-K EDGAR
  11. Apr 17, 2026SCHEDULE 13D/A EDGAR
  12. Apr 16, 20266-K EDGAR
  13. Mar 31, 20266-K EDGAR
  14. Mar 23, 20266-K EDGAR
  15. Mar 11, 20266-K EDGAR
  16. Mar 9, 20266-K EDGAR
  17. Mar 5, 20266-K EDGAR
  18. Mar 3, 20266-K EDGAR
  19. Feb 24, 20266-K EDGAR
  20. Feb 20, 20266-K EDGAR

The 175 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 68. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Tidal Investments LLC2,164,878$2.2M0.0%−3,519
Renaissance Technologies LLC1,444,148$1.5M0.0%−195,900
AdvisorShares Investments LLC888,057$905.8K0.1%−59,383
Goldman Sachs Group Inc611,479$623.7K0.0%+40,110
Morgan Stanley308,108$314.3K0.0%−56,076
Baader Bank Aktiengesellschaft250,000$254.5K0.0%−12,980
Bank Of Montreal /can/238,434$243.5K0.0%+380
Formidable Asset Management, LLC160,311$214.8K0.0%+3,562
UBS Group AG208,770$212.9K0.0%+176,155
Leonteq Securities AG124,849$180.4K0.0%−13,662
Dimensional Fund Advisors LP164,139$167.4K0.0%−9,745
Susquehanna International Group, Llp153,605$156.7K0.0%+44,152
Old Mission Capital LLC147,136$150.1K0.0%New
Citadel Advisors LLC73,575$75.0K0.0%+60,088
Cidel Asset Management Inc72,942$74.3K0.0%+771
Mariner, LLC70,173$71.6K0.0%−1,805
Vontobel Holding Ltd.69,753$71.2K0.0%No change
Qube Research & Technologies Ltd64,142$65.4K0.0%−21,416
Toronto Dominion Bank48,713$49.8K0.0%−31,907
Two Sigma Investments, LP36,365$37.1K0.0%−50,605
PFS Partners, LLC28,000$28.6K0.0%+3,000
Wealth Enhancement Advisory Services, LLC28,965$28.0K0.0%−11
Citigroup Inc20,438$20.8K0.0%New
Wealthspire Advisors, LLC18,522$18.9K0.0%No change
StoneX Group Inc.17,630$18.2K0.0%+3,993

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How ORGANIGRAM GLOBAL INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARORGANIGRAM GLOBAL INC.1
  • CIK0001620737
  • Filer status<br>emerging growth company not an emerging growth company1
  • Incorporated inCanada12
  • Fiscal year endsSeptember 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1400-145 King St. West, Toronto, M5H 1J8, Ontario, Canada1
  • Phone506-232-44001
  • Shares outstanding134,461,029 shares as of Sep 30, 202512
  • AuditorPKF O’Connor Davies, LLP, New York, NY PCAOB ID 127; it also attests to the company’s internal control over financial reporting12
  • On EDGAR sinceApr 13, 20151
  • Filings320 in all: 6-K (257), SC 13G/A (9), 40-F (7), D (7), SC 13D/A (5), SUPPL (5), F-X (4), FWP (4)1
    All 19 form types

    EFFECT (3), F-10 (3), F-10/A (3), SCHEDULE 13D/A (3), 40-F/A (2), CT ORDER (2), SC 13G (2), 40FR12B (1), CERT (1), D/A (1), SC 13D (1)

  • Latest filingsAnnual report (40-F) Dec 16, 2025

Securities registered for trading

ClassSymbolExchange
Common SharesOGINASDAQ Global Select Market

From the cover page of the 40-F filed Dec 16, 2025 (Section 12(b) of the Exchange Act).12

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12